Ukraine vs Canada vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 91% | 92% |
| 2023 | 92% | 92% |
| 2022 | 74% | 92% |
| 2021 | 89% | 90% |
| 2020 | 85% | 90% |
| 2019 | 93% | 90% |
| 2018 | 91% | 90% |
| 2017 | 86% | 90% |
| 2016 | 42% | 89% |
| 2015 | 56% | 89% |
| 2014 | 56% | 90% |
| 2013 | 79% | 90% |
| 2012 | 79% | 89% |
| 2011 | 67% | 88% |
| 2010 | 56% | 90% |
| 2009 | 75% | 91% |
| 2008 | 94% | 93% |
| 2007 | 97% | 94% |
| 2006 | 98% | 93% |
| 2005 | 96% | 94% |
| 2004 | 99% | 94% |
| 2003 | 99% | 95% |
| 2002 | 99% | 95% |
| 2001 | 99% | 95% |
| 2000 | 99% | 96% |
| 1999 | 99% | 96% |
| 1998 | 96% | 96% |
| 1997 | 97% | 96% |
| 1996 | 92% | 97% |
| 1995 | 97% | 96% |
| 1994 | 96% | 97% |
| 1993 | 94% | 96% |
| 1992 | 90% | 94% |
| 1991 | - | 92% |
| 1990 | - | 89% |
| 1989 | - | 87% |
| 1988 | - | 85% |
| 1987 | - | 70% |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 88% | 92% |
| 2023 | 83% | 92% |
| 2022 | 73% | 92% |
| 2021 | 78% | 92% |
| 2020 | 81% | 92% |
| 2019 | 80% | 91% |
| 2018 | 69% | 91% |
| 2017 | 50% | 91% |
| 2016 | 19% | 91% |
| 2015 | 23% | 91% |
| 2014 | 23% | 91% |
| 2013 | 76% | 91% |
| 2012 | 76% | 91% |
| 2011 | 50% | 87% |
| 2010 | 52% | 89% |
| 2009 | 71% | 91% |
| 2008 | 90% | 92% |
| 2007 | 98% | 94% |
| 2006 | 98% | 95% |
| 2005 | 96% | 93% |
| 2004 | 99% | 91% |
| 2003 | 97% | 91% |
| 2002 | 99% | 88% |
| 2001 | 99% | 89% |
| 2000 | 99% | 89% |
| 1999 | 99% | 90% |
| 1998 | 98% | 90% |
| 1997 | 99% | 86% |
| 1996 | 99% | 90% |
| 1995 | 98% | 87% |
| 1994 | 97% | 93% |
| 1993 | 93% | 90% |
| 1992 | 88% | 89% |
| 1991 | - | 88% |
| 1990 | - | 88% |
| 1989 | - | 87% |
| 1988 | - | 86% |
| 1987 | - | 85% |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 88% | 83% |
| 2023 | 79% | 83% |
| 2022 | 62% | 83% |
| 2021 | 77% | 84% |
| 2020 | 81% | 84% |
| 2019 | 77% | 84% |
| 2018 | 67% | 71% |
| 2017 | 52% | 71% |
| 2016 | 26% | 70% |
| 2015 | 22% | 69% |
| 2014 | 22% | 55% |
| 2013 | 46% | 55% |
| 2012 | 46% | 70% |
| 2011 | 21% | 70% |
| 2010 | 48% | 56% |
| 2009 | 66% | 42% |
| 2008 | 84% | 28% |
| 2007 | 92% | 14% |
| 2006 | 96% | 14% |
| 2005 | 97% | 14% |
| 2004 | 98% | 14% |
| 2003 | 77% | 14% |
| 2002 | 48% | - |
| 2001 | 7% | - |
| 2000 | 4% | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
| 1991 | - | - |
| 1990 | - | - |
| 1989 | - | - |
| 1988 | - | - |
| 1987 | - | - |
The first measles dose reaches 91% of children aged 12–23 months in Ukraine and 92% in Canada: 1 percentage point more in Canada. The third DTP dose reaches 88% in Ukraine and 92% in Canada, 4 points more in Canada. The third hepatitis B dose reaches 88% in Ukraine and 83% in Canada, 5 points more in Ukraine. In 1992, the first measles dose reached 90% in Ukraine and 94% in Canada, 4 percentage points more in Canada.
Ukraine vs Canada: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 91% (2024) | 92% (2024) |
| DTP3 | 88% (2024) | 92% (2024) |
| HepB3 | 88% (2024) | 83% (2024) |
Ukraine and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Canada and nearby countries: measles vaccination (MCV1), % of children aged 12–23 months
Of Ukraine and its seven neighbors, the latest coverage of the first measles dose is highest in Hungary, at 99%, and lowest in Romania, at 78%; of Canada and the five nearby countries, the latest coverage of the first measles dose is highest in Cuba, at 99%, and lowest in Mexico, at 80%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1987–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.